Connective tissue structural integrity

Connective tissue structural integrity" refers to the capacity of connective tissue to resist mechanical forces such as tension, compression, and stretch, thereby maintaining the shape, support, and cohesive function of organs and tissues throughout the body. This capacity is largely due to the composition and organization of the extracellular matrix, primarily comprising collagen fibers (for tensile strength), elastic fibers (for elasticity), and ground substance (for compressive resistance and molecular exchange). The structural integrity of connective tissue is critical for proper organ function and overall body mechanics. Diverse diseases, such as genetic collagenopathies (e.g., Marfan syndrome), autoimmune conditions (e.g., lupus, rheumatoid arthritis), and nutritional deficiencies (e.g., scurvy), can compromise connective tissue integrity, leading to a spectrum of clinical problems involving weakness, fragility, or dysfunction of tissues and organs[1][5][6][7][8][4]. This entry does not map to a discrete molecular entity, such as a receptor or enzyme, and is therefore not an appropriate target for drug development in the biomedical sense. For specific druggable targets related to connective tissue integrity, one would typically refer to structural proteins themselves (e.g., "collagen type I alpha 1 chain") or regulatory enzymes (e.g., "matrix metalloproteinase-1")[1][5][6][9].

Other names

Connective tissue stabilityStructural integrity of connective tissueTissue mechanical strengthExtracellular matrix structural function